Proton Therapy Global Management launched

Proton Therapy and pharmaceutical investment company CareCapital have partnered to create a new company, Proton Therapy Global Management (PTGM).

According to the companies, PTGM will manage, design and develop a network of proton therapy centers in partnership with hospitals.

The London-based company will be managed by:
  • Vernon R. Loucks, chairman of the board;
  • Michael Sinclair, president and CEO;
  • Ronald Anderson, chief operating officer and executive vice president; and
  • Jerry Pogue, executive vice president of business development.

PTGM is currently working to fund the first five proton therapy centers in London and several U.S. cities, said the company.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.